The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

BGI Genomics Co., Ltd. is a holding company that engages in development of science and technology services in genomics field. Its business scope ranges from scientific, health, agricultural and informatics. The company was founded by Wang Jian on September 9, 1999 and is headquartered in Shenzhen, China.

The Centre hospitalier universitaire Sainte-Justine (CHU Sainte-Justine) is the largest mother and child centre in Canada and one of the four most important pediatric centres in North America. This university health centre is affiliated with the Université de Montréal, located in Montreal, Quebec, Canada.

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

Centre Hospitalier de lUniversite de Montreal owns and operates general hospitals. The firm provides inpatient and ambulatory care to its immediate urban clientele and specialized & ultra specialized services. The company was founded in 1995 and is headquartered in Montreal, Canada.

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Bayer HealthCare Ltd., established on 1995-08-25, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;food sales;Health food production;food production;Production of formula food for special medical purpose;Cosmetic production;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;internet sales(Except for products that require a license for sale);Food import and export;software development;software sales;Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Manufacturing of computer software, hardware and peripheral equipment;Software outsourcing service;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Special Equipment Repair;Import and export;Technology Import and Export;Import and export agency;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Seasun Biomaterials, Inc. provides NGS services and real time PCR based diagnostic products. Its products and services include diagnostics, therapeutics, genome sequencing, transcriptome, and metagenome. The company was founded by Hee Gyeong Park on May 20, 2012 and is headquartered in Daejeon, South Korea.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. Korro Bio was created to lead the field of RNA editing. The company is advancing a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. In 2018,

Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA.

Boao Biological Group Co., Ltd., established on 2000-09-30, The scope of business includes the production of instrumentation;6840In vitro diagnostic reagents,medical instruments,traditional Chinese medicine,biological reagent,Bioanalytical Instruments,biochip,Technology development of biochip accessory materials,Technical Services,Technology Promotion,technology transfer;software development;Basic software service,Application software service(Does not contain medical software);Sales instrumentation,Equipment,electronic product;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Import and export,Technology Import and Export,Agent import and export;Investment;investment management;lease commercial premises,office;Undertake the exhibition;Conference Services.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

Suzhou Baiyuan Gene Technology Co., Ltd., established on 2012-07-12, Business scope includes genomics,Basic Medicine,Preventive Medicine and Hygiene,pharmaceutical research;medical instruments,Chinese patent medicine,biopharmaceuticals,Healthy food,development of cosmetics;Non-hazardous teaching and research reagents,Teaching and scientific research equipment,Electronic and automation instrument,Wholesale of medical devices,retail;Production of Medical Devices;Technical consultation related to the above products,technology transfer,Technical service and technical outsourcing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Import and export;Technology Import and Export;Import and export agency;Drug import and export;Import and export of goods managed by state trade;Import and export commodity inspection and appraisal(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Hardware retail;Sales of special labor protection products;Chemical product sales(No licensed chemical products);Arts and crafts and etiquette supplies sales(Except for ivory and its products);Communication equipment sales;Sales of electronic components and electromechanical components;Sales of mechanical and electrical equipment;Textile,Wholesale of Clothing and Household Goods;Specialty Chemicals Sales(Free of Hazardous Chemicals);General merchandise sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuxi Zhongde Meilian Biotechnology Co., Ltd., established on 2006-12-05, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Production of formula food for special medical purpose;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Research and development of bio-based materials technology;Manufacturing of bio-based materials;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);rental service(Licensed rental services not included);Import and export;Technology Import and Export;Conference and Exhibition Services;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Information Technology Consulting Services;Labor service(Does not include labor dispatch)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Jiangsu Provincial People's Hospital, a subsidiary of Nanjing Medical University, is a company headquartered in Guangzhou, China. The firm operates hospitals.